Nanjing Hicin Pharmaceutical announces revenue of 166 million yuan in 2020 Q1

On April 21, Hicin Pharmaceutical released a report for the first quarter of 2020, with revenue of 166 million yuan, down 21.09% from the same period last year, and net profit of 17.1673 million yuan, down 22.91% from the same period last year.

On April 21, Hicin Pharmaceutical released a report for the first quarter of 2020, with revenue of 166 million yuan, down 21.09% from the same period last year, and net profit of 17.1673 million yuan, down 22.91% from the same period last year.

The company said that during the epidemic, the company’s raw material procurement, production, logistics and distribution, and commercial promotion were restricted to a certain extent.

Production and operation were affected to a certain extent, resulting in a decrease in sales orders in the first quarter and a decline in the company’s operating revenue and profits.

Disclaimer: This is an article created by Michael Liang for Chinasdg.org. You can find the original article here: https://chinasdg.org/2020/04/22/nanjing-hicin-pharmaceutical-announces-revenue-of-166-million-yuan-in-2020-q1/.

Leave a Reply

Please Login to Comment